Search - tctmd.com

Displaying 1 - 20 of 103

Sort: Relevancy | Date

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

L.A. McKeown

December 29, 2022

News Daily News

CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults

Michael O'Riordan

December 28, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says

L.A. McKeown

December 14, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Caitlin E. Cox

December 06, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Todd Neale

November 29, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

Caitlin E. Cox

November 18, 2022

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

Todd Neale

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Todd Neale

November 05, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

Shelley Wood

October 31, 2022

Advertisement

The Biggest News of 2022: TCTMD’s Top 10

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

In the US, COVID Reversed CV Mortality Gains, Hitting Black Americans Hardest

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Age-Related Macular Degeneration Linked to Severe Vascular Disease

Many STEMI Patients Not Treated Within National Time Goals

Sizeable Minority of Pregnant Women Have CVD, US Data Show

China Rural Intervention Still Reaping BP Control Wins at 3 Years

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

TCTMD’s Top 10 Most Popular Stories for October 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content